Phase 2 COPD Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults between the ages of 40 and 80
- People whose breathing test results (taken after using an inhaler) show a specific pattern of reduced lung function, measured within a certain range (confirm with trial site for exact values)
- People who have been using a stable combination of three inhaled lung medicines for at least 3 months
- People who are former smokers with at least a 10 pack-year smoking history and who have not smoked for at least 6 months
- People whose blood tests show an elevated level of a certain type of immune cell called eosinophils
- People whose weight and body mass index (a measure of body size) fall within the range allowed by the trial
Who may not be able to join:
- People with a significant lung condition other than COPD (chronic obstructive pulmonary disease)
- People with serious other health conditions or active infections that the trial doctor believes could affect safety or how the study runs
- People with significant heart or cardiovascular disease
- People who have had a recent chest infection or a flare-up of their COPD
- People who have recently used certain approved or experimental biologic medicines for COPD without enough time having passed since their last dose
- People who are pregnant or breastfeeding
- People who currently smoke or who have a diagnosed substance use disorder
- People with any other condition or circumstance that the trial doctor believes would make participation unsafe or affect the reliability of the study
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Omar Khwaja, MD, Windward Bio
Phone: +4161 551 75 75
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Number of participants with Adverse Events (AEs); Number of participants with Serious Adverse Events (SAEs); Change from baseline in systolic blood pressure (mmHg); Change from baseline in diastolic blood pressure (mmHg); Change from baseline in pulse rate (beats/minute); Change from baseline in respiratory rate (breaths/minute); Change from baseline in oxygen saturation (%); Change from baseline in body weight (kg); Change from baseline in body mass index (kg/m^2); Change from baseline in body temperature (°C); Change from baseline in clinical chemistry laboratory assessments; Change from bas...
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.